Literature DB >> 23063552

Global profiling strategies for mapping dysregulated metabolic pathways in cancer.

Daniel I Benjamin1, Benjamin F Cravatt, Daniel K Nomura.   

Abstract

Cancer cells possess fundamentally altered metabolism that provides a foundation to support tumorigenicity and malignancy. Our understanding of the biochemical underpinnings of cancer has benefited from the integrated utilization of large-scale profiling platforms (e.g., genomics, proteomics, and metabolomics), which, together, can provide a global assessment of how enzymes and their parent metabolic networks become altered in cancer to fuel tumor growth. This review presents several examples of how these integrated platforms have yielded fundamental insights into dysregulated metabolism in cancer. We will also discuss questions and challenges that must be addressed to more completely describe, and eventually control, the diverse metabolic pathways that support tumorigenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23063552      PMCID： PMC3539740          DOI： 10.1016/j.cmet.2012.09.013

Source DB:  PubMed          Journal:  Cell Metab        ISSN： 1550-4131            Impact factor:   27.287


  73 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

3.  Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis.

Authors:  Jason W Locasale; Alexandra R Grassian; Tamar Melman; Costas A Lyssiotis; Katherine R Mattaini; Adam J Bass; Gregory Heffron; Christian M Metallo; Taru Muranen; Hadar Sharfi; Atsuo T Sasaki; Dimitrios Anastasiou; Edouard Mullarky; Natalie I Vokes; Mika Sasaki; Rameen Beroukhim; Gregory Stephanopoulos; Azra H Ligon; Matthew Meyerson; Andrea L Richardson; Lynda Chin; Gerhard Wagner; John M Asara; Joan S Brugge; Lewis C Cantley; Matthew G Vander Heiden
Journal:  Nat Genet       Date:  2011-07-31       Impact factor: 38.330

Review 4.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

5.  Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.

Authors:  Daniel K Nomura; Donald P Lombardi; Jae Won Chang; Sherry Niessen; Anna M Ward; Jonathan Z Long; Heather H Hoover; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2011-07-29

6.  Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes.

Authors:  Margaret Wu; Sheo B Singh; Jun Wang; Christine C Chung; Gino Salituro; Bindhu V Karanam; Sang Ho Lee; Maryann Powles; Kenneth P Ellsworth; Michael E Lassman; Corey Miller; Robert W Myers; Michael R Tota; Bei B Zhang; Cai Li
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-09       Impact factor: 11.205

7.  Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content.

Authors:  Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Giovanni Mazzarol; Manuela Vecchi; Simona Ronzoni; Loris Bernard; Giuseppe Viale; Pier Giuseppe Pelicci; Pier Paolo Di Fiore
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

Review 8.  Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.

Authors:  Michèle Sabbah; Shahin Emami; Gérard Redeuilh; Sylvia Julien; Grégoire Prévost; Amazia Zimber; Radia Ouelaa; Marc Bracke; Olivier De Wever; Christian Gespach
Journal:  Drug Resist Updat       Date:  2008-08-20       Impact factor: 18.500

9.  Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.

Authors:  Wei Xu; Hui Yang; Ying Liu; Ying Yang; Ping Wang; Se-Hee Kim; Shinsuke Ito; Chen Yang; Pu Wang; Meng-Tao Xiao; Li-xia Liu; Wen-qing Jiang; Jing Liu; Jin-ye Zhang; Bin Wang; Stephen Frye; Yi Zhang; Yan-hui Xu; Qun-ying Lei; Kun-Liang Guan; Shi-min Zhao; Yue Xiong
Journal:  Cancer Cell       Date:  2011-01-18       Impact factor: 38.585

10.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Authors:  Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040
View more
  56 in total

1.  Metabolic profiling reveals PAFAH1B3 as a critical driver of breast cancer pathogenicity.

Authors:  Melinda M Mulvihill; Daniel I Benjamin; Xiaodan Ji; Erwan Le Scolan; Sharon M Louie; Alice Shieh; McKenna Green; Tara Narasimhalu; Patrick J Morris; Kunxin Luo; Daniel K Nomura
Journal:  Chem Biol       Date:  2014-06-19

2.  Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: a pilot study.

Authors:  Gunjal Garg; Ali Yilmaz; Praveen Kumar; Onur Turkoglu; David G Mutch; Matthew A Powell; Barry Rosen; Ray O Bahado-Singh; Stewart F Graham
Journal:  Metabolomics       Date:  2018-11-24       Impact factor: 4.290

Review 3.  Peroxisomal Dysfunction in Age-Related Diseases.

Authors:  Cynthia M Cipolla; Irfan J Lodhi
Journal:  Trends Endocrinol Metab       Date:  2017-01-04       Impact factor: 12.015

4.  High-Throughput Indirect Quantitation of 13C Enriched Metabolites Using 1H NMR.

Authors:  Valentina Di Gialleonardo; Sui Seng Tee; Hannah N Aldeborgh; Vesselin Z Miloushev; Lidia S Cunha; George D Sukenick; Kayvan R Keshari
Journal:  Anal Chem       Date:  2016-10-26       Impact factor: 6.986

Review 5.  Metabolism and immunity in breast cancer.

Authors:  Deyu Zhang; Xiaojie Xu; Qinong Ye
Journal:  Front Med       Date:  2020-10-19       Impact factor: 4.592

6.  Activity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer.

Authors:  Rebecca A Kohnz; Melinda M Mulvihill; Jae Won Chang; Ku-Lung Hsu; Antonio Sorrentino; Benjamin F Cravatt; Sourav Bandyopadhyay; Andrei Goga; Daniel K Nomura
Journal:  ACS Chem Biol       Date:  2015-05-07       Impact factor: 5.100

7.  Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.

Authors:  Venkatrao Vantaku; Sri Ramya Donepudi; Danthasinghe Waduge Badrajee Piyarathna; Chandra Sekhar Amara; Chandrashekar R Ambati; Wei Tang; Vasanta Putluri; Darshan S Chandrashekar; Sooryanarayana Varambally; Martha K Terris; Kimberly Davies; Stefan Ambs; Roni Bollag; Andrea B Apolo; Arun Sreekumar; Nagireddy Putluri
Journal:  Cancer       Date:  2019-01-02       Impact factor: 6.860

8.  Non-invasive fecal metabonomic detection of colorectal cancer.

Authors:  Lee Cheng Phua; Xiu Ping Chue; Poh Koon Koh; Peh Yean Cheah; Han Kiat Ho; Eric Chun Yong Chan
Journal:  Cancer Biol Ther       Date:  2014-01-14       Impact factor: 4.742

9.  GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity.

Authors:  Sharon M Louie; Elizabeth A Grossman; Lisa A Crawford; Lucky Ding; Roman Camarda; Tucker R Huffman; David K Miyamoto; Andrei Goga; Eranthie Weerapana; Daniel K Nomura
Journal:  Cell Chem Biol       Date:  2016-05-12       Impact factor: 8.116

10.  Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity.

Authors:  Daniel I Benjamin; Alyssa Cozzo; Xiaodan Ji; Lindsay S Roberts; Sharon M Louie; Melinda M Mulvihill; Kunxin Luo; Daniel K Nomura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.